The race for a COVID-19 vaccine is on, and as the disease continues to upend societies around the world, public health officials are calling upon pharmaceutical companies to share their intellectual property—a move that could speed up research and make any eventual treatment more widely (and easily) accessible, says Northeastern law professor Brook Baker. Sharing […]
